V-BIOTEK HOLDING ApS: Financial statements 2023
CVR: 30525299
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
V-BIOTEK HOLDING ApS (CVR 30525299) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 67,394 and a net result of DKK -736,590 compared with DKK -1,929,547 the year before. That is an increase of 56.7% compared with the year before. The profit margin was -1,093%. Equity in the 2023 report amounted to DKK 2,368,005. The solvency ratio was 45.6%.
- Revenue
- DKK 67,394
- Gross Profit
- DKK -71,210
- Profit/Loss
- DKK -736,590
- Equity
- DKK 2,368,005
- Total Assets
- DKK 5,189,520
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 67K | -71K | -737K | 2.4M | - |
| 2022 | 43K | -70K | -1.9M | 3.1M | - |
| 2021 | - | 239K | -405K | 5M | - |
| 2020 | - | 389K | 52K | 5.4M | - |
| 2019 | - | -16K | 6.8M | 5.4M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout V-BIOTEK HOLDING ApS
V-BIOTEK HOLDING ApS is a Danish company of the type Anpartsselskab based in Havdrup, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jens Steen Olsen. The company's owners include ØYAN HOLDING ApS, STEEN HANSEN HOLDING A/S and SVONI HOLDING ApS. The company has 0 employees (2012). In 2025, the company reported revenue of DKK 56,769 and a net result of DKK 85,971 compared with DKK -863,949 the year before. Equity in the 2025 report amounted to DKK 1,590,028.